<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03503877</url>
  </required_header>
  <id_info>
    <org_study_id>17-22331</org_study_id>
    <nct_id>NCT03503877</nct_id>
  </id_info>
  <brief_title>Media, Morphokinetics, and Mosaicism</brief_title>
  <acronym>3M</acronym>
  <official_title>Aneuploidy Rates and Morphokinetic Parameters in Sibling Embryos Cultured in Distinct Culture Media</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Embryonic aneuploidy is the underlying etiology for the majority of failed implantation and
      miscarriage. Preimplantation genetic screening (PGS) with transfer of a euploid embryo has
      been advocated as a strategy for increasing live birth rates with a single embryo transfer.
      Culturing embryos to the blastocyst stage for trophectoderm biopsy is a requirement for PGS.
      Several commercially-available single-step embryonic culture media with varying composition
      have been established for use in the IVF laboratory. Early reports have suggested differences
      in clinical outcomes, such as aneuploidy and miscarriage rates, with distinct culture media
      currently in standard use.1,2 However, there have been no clinical trials demonstrating the
      superiority of any one commercially-available culture media formulation. As a result, clinics
      use media with varying composition based upon familiarity and cost.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 14, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 14, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>sibling embryo study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>aneuploidy rates</measure>
    <time_frame>2 weeks</time_frame>
    <description>number of embryos with abnormal chromosome number over total number of embryos biopsied</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>embryo quality</measure>
    <time_frame>2 weeks</time_frame>
    <description>fraction of freezable quality embryos (6c or greater, grades 1-2 for symmetry and fragmentation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>embryonic mosaicism</measure>
    <time_frame>2 weeks</time_frame>
    <description>fraction of embryos defined as mosiac (number of embryos with partial aneuploidy over total number of embryos biopsied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>embryo morphokinetics</measure>
    <time_frame>2 weeks</time_frame>
    <description>time of first and subsequent cleavage, time between cleavages</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Embryonic Mosaicism</condition>
  <condition>Embryo Culture Media</condition>
  <condition>Embryo Morphokinetics</condition>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>SAGE Media</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>SAGE single-step MEDIA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GLOBAL Media</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>LIFE GLOBAL single-step MEDIA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EmbryoScope Plus</intervention_name>
    <description>All embryos in both arms will be cultured in the EmbryoScope Plus to obtain morphokinetic data</description>
    <arm_group_label>SAGE Media</arm_group_label>
    <arm_group_label>GLOBAL Media</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>GLOBAL MEDIA</intervention_name>
    <description>Embryos will be cultured in GLOBAL media</description>
    <arm_group_label>GLOBAL Media</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SAGE MEDIA</intervention_name>
    <description>Embryos will be cultured in SAGE media</description>
    <arm_group_label>SAGE Media</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All subjects planning blastocyst culture for preimplantation genetic screening (PGS) will
        be offered enrollment.

        AFC &gt;8 Male and female partner &gt; 18 years of age

        Exclusion Criteria:

        Female partner age &gt;42 years of age Cleavage stage biopsy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Molly Quinn, MD</last_name>
    <phone>4153537475</phone>
    <email>molly.quinn@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Quinn, MD</last_name>
      <phone>415-353-7475</phone>
      <email>molly.quinn@ucsf.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2018</study_first_submitted>
  <study_first_submitted_qc>April 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

